Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease (vol 27, pg 106, 2021)

被引：0
|
作者：
Daneses, Silvio [1 ,2 ,3 ]
机构：
[1] Humanitas Clin & Res Ctr IRCCS, Dept Gastroenterol, IBD Ctr, Rozzano, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Humanitas Clin & Res Ctr, Dept Gastroenterol, IBD Ctr, Milan, Italy
来源：
JOURNAL OF ANIMAL SCIENCE | 2022年 / 100卷 / 09期
关键词：
D O I：
暂无
中图分类号：
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号：
0905 ;
摘要：
引用
收藏
页码：1367 / 1367
页数：1
相关论文
共 50 条
  • [21] Predictors of Perianal Fistula Relapse in Crohn's Disease (vol 27, pg 1365, 2021)
    Malian, Audrey
    Riviere, Pauline
    Bouchard, Dominique
    Pigot, Francois
    Eleouet-Kaplan, Marianne
    Favreau-Weltzer, Charlotte
    Poullenot, Florian
    Laharie, David
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (08) : 1365 - 1365
  • [22] Adalimumab for Crohn's Disease in Clinical Practice at Mayo Clinic: The First 118 Patients
    Swoger, Jason M.
    Loftus, Edward V., Jr.
    Tremaine, William J.
    Faubion, William A.
    Pardi, Darrell S.
    Kane, Sunanda V.
    Hanson, Karen A.
    Harmsen, W. Scott
    Zinsmeister, Alan R.
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (11) : 1912 - 1921
  • [23] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [24] Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. -C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    De Vos, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S274
  • [25] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [26] Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis
    Keil, Radan
    Wasserbauer, Martin
    Zadorova, Zdena
    Hajer, Jan
    Drastich, Pavel
    Wohl, Pavel
    Benes, Marek
    Bojkova, Martina
    Svoboda, Pavel
    Konecny, Michal
    Falt, Premysl
    Vanasek, Tomas
    Pesta, Martin
    Pesek, Frantisek
    Bouchner, Ludek
    Kozeluhova, Jana
    Novotny, Ales
    Bartuskova, Lucie
    Spicak, Julius
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1062 - 1068
  • [27] Adalimumab is effective in patients with fistulizing Crohn's disease who were primary nonresponders to infliximab treatment
    Lichtiger, Simon
    Binion, David
    Wolf, Douglas
    Present, Daniel
    Lomax, Kathleen
    Rafiq, Shuvobrata
    Holdbrook, Fred
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S416 - S416
  • [28] Adalimumab for the treatment of fistulas in patients with Crohn's disease
    Colombel, J-F
    Schwartz, D. A.
    Sandborn, W. J.
    Kamm, M. A.
    D'Haens, G.
    Rutgeerts, P.
    Enns, R.
    Panaccione, R.
    Schreiber, S.
    Li, J.
    Kent, J. D.
    Lomax, K. G.
    Pollack, P. F.
    GUT, 2009, 58 (07) : 940 - 948
  • [29] Observational Study of Treatment Patterns in Patients Newly Initiated with Adalimumab or Infliximab Therapy for Crohn's Disease
    Plevy, Scott
    Lu, M.
    Yu, Andrew
    Sharma, Hari
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S479 - S479
  • [30] Adalimumab for the Treatment of Fistulas in Patients with Crohn's Disease
    Fine, Steven N.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (02) : 667 - 668
12345